Dawah Pharmaceuticals Inc. aims to be a global sterile injectable and ophthalmology market leader by building a state-of-the-art sterile manufacturing facility in the US, meeting global regulatory standards. Dawah has brought together an unstoppable team with over 200 years of experience in the pharmaceutical industry, with a specific focus on the sterile injectable and ophthalmic fields. We can confidently say that we will build a $400m company with a world-class product portfolio in the next five years.
Market shortages and lack of competition, especially in complex generics, dictate an opportunity to infiltrate the lucrative sterile injectable market. With a team of talented and highly experienced scientists and seasoned business professionals, Dawah Pharmaceuticals Inc. is well on its way to a successful future.